This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medicus International New York Appoints Bernstein As Group Medical Director

NEW YORK, Dec. 6, 2012 /PRNewswire/ -- Medicus International New York, a full-service scientific communications agency specializing in scientific publications and medical education, announced that Deborah R. Bernstein, M.D., has been appointed Vice President, Group Medical Director. Medicus International New York is a division of Publicis Healthcare Communications Group, the largest healthcare communications network in the world.

In her new role, Dr. Bernstein will be responsible for overseeing the development and execution of scientific content and promotional medical education activities, serving as a liaison to medical affairs groups and building relationships with industry thought leaders. Dr. Bernstein, a board certified internist, brings more than 20 years of clinical experience and 10 years of promotional medical education and healthcare professional advertising experience to Medicus International New York. Dr. Bernstein most recently served as Senior Vice President, Medical Director, at AgencyRx in New York.

Dr. Bernstein said, "I am thrilled to be working at Medicus International New York, spearheading projects that will make a difference in patient care across a host of disease states and areas. I look forward to leveraging our best-in-class, high-science expertise and understanding to create innovative and dynamic programs."

Edward Cowen, Managing Director, Medicus International New York, said, "We're excited to welcome Dr. Deborah Bernstein's appointment to our leadership team. Her extensive, hands-on knowledge and clinical insight into how doctors think and learn will enhance our medical education offerings and help us best communicate complex clinical messaging."

About Medicus International New YorkMedicus International New York (MINY) is a full-spectrum scientific communications agency, with expertise in evidence-based planning, publications, scientific narrative development, advisory boards, speaker training, congress planning, and multimedia educational tool development.  For more information, visit www.medicusintny.com.

Contact: Edward CowenManaging Director, Medicus International New YorkPhone: +1.212.448.6802Email: edward.cowen@medicusintny.com

SOURCE Medicus International New York

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs